Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
STK17A is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. Additionally we are shipping serine/threonine Kinase 17a Antibodies (102) and serine/threonine Kinase 17a Kits (1) and many more products for this protein.
Showing 7 out of 7 products:
the present study was the first to find localization of STK17A in normal bile canaliculi.
DRAK1 was predominantly localized in the cytoplasm and bound to Smad3 (show SMAD3 Proteins), thereby interrupting Smad3 (show SMAD3 Proteins)/Smad4 (show SMAD4 Proteins) complex formation, which is the core process for the induction of tumor suppressor genes by TGF-beta1 (show TGFB1 Proteins)
STK17A provides a proliferative and survival advantage to GBM cells
When analyzing STK17A haplotypes distribution, we found association between TGGTC, TAGTC and AAGAT haplotypes and risk to develop SLE
identified STK17A as a novel direct target of p53 (show TP53 Proteins) and a modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.
This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
serine/threonine kinase 17a
, DAP kinase-related apoptosis-inducing protein kinase 1
, serine/threonine-protein kinase 17A-like
, death-associated protein kinase-related 1
, serine/threonine kinase 17a (apoptosis-inducing)
, serine/threonine-protein kinase 17A